Amarantus Bioscience Holdings Inc. announced the appointment of Mr. Iain Ross to the Company's Board of Directors, Mr. Ross brings over 30 years of biopharmaceutical industry experience to Amarantus across executive management, investment and directorship roles. Currently he is Chairman of the Board of Ark Therapeutics Group PLC and Biomer Technology Ltd, and is also a Non-Executive Director of Benitec Biopharma Limited, Novogen Limited and Tissue Therapies Ltd. each of which is traded on the Australian Securities Exchange.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
0.00% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 630 | |
+47.23% | 56.61B | |
-7.66% | 39.62B | |
+35.76% | 39.25B | |
-6.90% | 28.28B | |
+10.80% | 26.44B | |
-16.54% | 20.12B | |
+28.46% | 12.51B | |
+30.03% | 12.48B | |
+0.26% | 12.2B |
- Stock Market
- Equities
- AMBS Stock
- News Amarantus BioScience Holdings, Inc.
- Amarantus Bioscience Holdings, Inc Appoints Iain Ross to Board of Directors